Company intelligence / Profile preview

IPG Pharmaceutical

Ownership: Private
Development stage: Other

Overview

IPG is a pharmaceutical service provider and supply chain manager, specializing in sourcing and supplying active pharmaceutical ingredients (APIs), finished dose generics, and evidence-based cosmeceuticals. It assists clients in obtaining regulatory approvals, managing complex global supply chains, and supporting product launches and tech transfers for generic pharma companies, particularly in Europe, Middle East, and Asia. The company is MHRA/FDA approved, holds various certifications, and has a strong operational footprint in Asia and the UK.

Modalities: Small moleculeCosmeceutical
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on IPG Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPG Pharmaceutical.

Explore the full profile